Severity also appeared to decline, as indicated by a decreasing proportion of cases meeting a criterion for one of the SM syndromes (BCS <3, respiratory distress, or Hb <50 g/L) over the thirteen-year study period (Chi-square for trend, P<0.001). This evidence concerns the gene GSTM1 and systemic mastocytosis.